WA
ALXN

WESPAC Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

WESPAC Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,422
Closed -$217K – 177
2021
Q1 		$217K Buy
+1,422
New +$217K 0.16% 153